% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • bicster58 bicster58 Mar 28, 2012 7:50 PM Flag

    Surprise acquisition

    (Gobblenewswire) Today, March 28th, in a move that has startled most Wall Street analysts, Apricus Biosciences announced the acquisition of Krunchy Kreme, Inc. The deal, to be finalized next week, is rumored to be in excess of $260 million in cash and stock (approximately 26.5 million in cash and 80 million shares of common). In a late afternoon press conference, CEO of Apricus Biosciences , Dr. Bassam Damaj, stated that “We are very excited about the acquisition of Krunchy Kreme, and extremely pleased with the terms. We are confident that the synergies created by the merging of our two companies will greatly expand the marketability and profit potential of both of our product lines. Over the past few months, Krunchy Kreme has been conducting in-depth studies of the effect of incorporating Nexact technology into its fabricated doughnuts, and has shown us convincing data demonstrating that Nexact enhances both nutritional value and digestibility. We feel that this merger, utilizing our recently acquired sales staff, will quickly propel Apricus Biosciences into a leading provider of both Erectile Dysfunction treatments and world-class pastries.”

    The CEO of Krunchy Kreme, R.S.Bicster, in a very brief press conference, appeared choked with emotion, often covering his face with his hands and wiping tears from his eyes. After regaining his composure, he made only one short statement: “I can’t f&@king believe it!”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.53-0.02(-1.29%)May 26 4:00 PMEDT